SBF2 and glioma: According to Zhang et al., the expression of lncRNA SET-binding factor 2 antisense RNA 1 (SBF2-AS1) is upregulated in TMZ-resistant glioma tissues as compared with TMZ-sensitive tissues, indicating that SBF2-AS1 is associated with chemoresistance to TMZ [48].